{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-066051","form_type":"8-K","ticker":"ORIC","cik":"0001796280","company_name":"Oric Pharmaceuticals, Inc.","filed_at":"2022-03-04T23:59:59+00:00","discovered_at":"2026-05-14T18:04:08.255728+00:00","generated_at":"2026-06-27T01:40:29.360865+00:00","sec_items":["5.02","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"ORIC Pharmaceuticals adopts 2022 Inducement Equity Incentive Plan reserving 500,000 shares","bullets":["Plan adopted March 1, 2022 by Compensation Committee; 500,000 shares of common stock reserved.","Awards limited to new employees as material inducement to hire, per Nasdaq Listing Rule 5635(c)(4).","Terms substantially similar to company's 2020 Equity Incentive Plan.","Adopted without stockholder approval; approved by independent directors."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-066051","json":"https://secwatch.observer/filing/0001193125-22-066051.json","markdown":"https://secwatch.observer/filing/0001193125-22-066051.md","text":"https://secwatch.observer/filing/0001193125-22-066051.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1796280/000119312522066051/0001193125-22-066051-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1796280/000119312522066051/d253295d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T01:40:29.360865+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}